Cargando…

Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [(11)C]-Acetate PET/CT

Purpose: Dynamic [(11)C]-acetate positron emission tomography (PET) can be used to study tissue perfusion and carbon flux simultaneously. In this study, the feasibility of the quantification of prostate cancer aggressiveness using parametric methods assessing [(11)C]-acetate kinetics was investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Regula, Naresh, Honarvar, Hadis, Lubberink, Mark, Jorulf, Håkan, Ladjevardi, Sam, Häggman, Michael, Antoni, Gunnar, Buijs, Jos, Velikyan, Irina, Sörensen, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990881/
https://www.ncbi.nlm.nih.gov/pubmed/32038105
http://dx.doi.org/10.7150/ijms.39542
_version_ 1783492563398819840
author Regula, Naresh
Honarvar, Hadis
Lubberink, Mark
Jorulf, Håkan
Ladjevardi, Sam
Häggman, Michael
Antoni, Gunnar
Buijs, Jos
Velikyan, Irina
Sörensen, Jens
author_facet Regula, Naresh
Honarvar, Hadis
Lubberink, Mark
Jorulf, Håkan
Ladjevardi, Sam
Häggman, Michael
Antoni, Gunnar
Buijs, Jos
Velikyan, Irina
Sörensen, Jens
author_sort Regula, Naresh
collection PubMed
description Purpose: Dynamic [(11)C]-acetate positron emission tomography (PET) can be used to study tissue perfusion and carbon flux simultaneously. In this study, the feasibility of the quantification of prostate cancer aggressiveness using parametric methods assessing [(11)C]-acetate kinetics was investigated in prostate cancer subjects. The underlying uptake mechanism correlated with [(11)C]-acetate influx and efflux measured in real-time in vitro in cell culture. Methods: Twenty-one patients with newly diagnosed low-to-moderate risk prostate cancer underwent magnetic resonance imaging (MRI) and dynamic [(11)C]-acetate PET/CT examinations of the pelvis. Parametric images of K(1) (extraction × perfusion), k(2) (oxidative metabolism) and V(T) (=K(1)/k(2), anabolic metabolism defined as carbon retention) were constructed using a one-tissue compartment model with an arterial input function derived from pelvic arteries. Regions of interest (ROIs) of the largest cancer lesion in each patient and normal prostate tissue were drawn using information from MRI (T2 and DWI images), biopsy results, and post-surgical histopathology of whole prostate sections (n=7). In vitro kinetics of [(11)C]-acetate were studied on DU145 and PC3 cell lines using LigandTracer(®) White equipment for the measurement of the radioactivity uptake in real-time at 37°C. Results: Mean prostate specific antigen (PSA) was 8.33±3.92 ng/mL and median Gleason Sum 6 (range 5-7). K(1), V(T) and standardized uptake values (SUVs) were significantly higher in cancerous prostate tissues compared to normal ones for all patients (p<0.001), while k(2) was not (p=0.26). PSA values correlated to early SUVs (r=0.50, p=0.02) and K(1) (r=0.48, p=0.03). Early and late SUVs correlated to V(T) (r>0.76, p<0.001) and K(1) (r>0.64, p<0.005). In vitro studies demonstrated higher extraction and retention (p<0.01) of [(11)C]-acetate in the more aggressive PC3 cells. Conclusion: Parametric images could be used to visualize the [(11)C]-acetate kinetics of the prostate cancer exhibiting elevated extraction associated with the cancer aggressiveness. The influx rate of [(11)C]-acetate studied in cell culture also showed dependence on the cancer aggressiveness associated with elevated lipogenesis. Dynamic [(11)C]-acetate/PET demonstrated potential for prostate cancer aggressiveness estimation using parametric-based K(1) and V(T) values.
format Online
Article
Text
id pubmed-6990881
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-69908812020-02-09 Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [(11)C]-Acetate PET/CT Regula, Naresh Honarvar, Hadis Lubberink, Mark Jorulf, Håkan Ladjevardi, Sam Häggman, Michael Antoni, Gunnar Buijs, Jos Velikyan, Irina Sörensen, Jens Int J Med Sci Research Paper Purpose: Dynamic [(11)C]-acetate positron emission tomography (PET) can be used to study tissue perfusion and carbon flux simultaneously. In this study, the feasibility of the quantification of prostate cancer aggressiveness using parametric methods assessing [(11)C]-acetate kinetics was investigated in prostate cancer subjects. The underlying uptake mechanism correlated with [(11)C]-acetate influx and efflux measured in real-time in vitro in cell culture. Methods: Twenty-one patients with newly diagnosed low-to-moderate risk prostate cancer underwent magnetic resonance imaging (MRI) and dynamic [(11)C]-acetate PET/CT examinations of the pelvis. Parametric images of K(1) (extraction × perfusion), k(2) (oxidative metabolism) and V(T) (=K(1)/k(2), anabolic metabolism defined as carbon retention) were constructed using a one-tissue compartment model with an arterial input function derived from pelvic arteries. Regions of interest (ROIs) of the largest cancer lesion in each patient and normal prostate tissue were drawn using information from MRI (T2 and DWI images), biopsy results, and post-surgical histopathology of whole prostate sections (n=7). In vitro kinetics of [(11)C]-acetate were studied on DU145 and PC3 cell lines using LigandTracer(®) White equipment for the measurement of the radioactivity uptake in real-time at 37°C. Results: Mean prostate specific antigen (PSA) was 8.33±3.92 ng/mL and median Gleason Sum 6 (range 5-7). K(1), V(T) and standardized uptake values (SUVs) were significantly higher in cancerous prostate tissues compared to normal ones for all patients (p<0.001), while k(2) was not (p=0.26). PSA values correlated to early SUVs (r=0.50, p=0.02) and K(1) (r=0.48, p=0.03). Early and late SUVs correlated to V(T) (r>0.76, p<0.001) and K(1) (r>0.64, p<0.005). In vitro studies demonstrated higher extraction and retention (p<0.01) of [(11)C]-acetate in the more aggressive PC3 cells. Conclusion: Parametric images could be used to visualize the [(11)C]-acetate kinetics of the prostate cancer exhibiting elevated extraction associated with the cancer aggressiveness. The influx rate of [(11)C]-acetate studied in cell culture also showed dependence on the cancer aggressiveness associated with elevated lipogenesis. Dynamic [(11)C]-acetate/PET demonstrated potential for prostate cancer aggressiveness estimation using parametric-based K(1) and V(T) values. Ivyspring International Publisher 2020-01-14 /pmc/articles/PMC6990881/ /pubmed/32038105 http://dx.doi.org/10.7150/ijms.39542 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Regula, Naresh
Honarvar, Hadis
Lubberink, Mark
Jorulf, Håkan
Ladjevardi, Sam
Häggman, Michael
Antoni, Gunnar
Buijs, Jos
Velikyan, Irina
Sörensen, Jens
Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [(11)C]-Acetate PET/CT
title Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [(11)C]-Acetate PET/CT
title_full Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [(11)C]-Acetate PET/CT
title_fullStr Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [(11)C]-Acetate PET/CT
title_full_unstemmed Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [(11)C]-Acetate PET/CT
title_short Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [(11)C]-Acetate PET/CT
title_sort carbon flux as a measure of prostate cancer aggressiveness: [(11)c]-acetate pet/ct
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990881/
https://www.ncbi.nlm.nih.gov/pubmed/32038105
http://dx.doi.org/10.7150/ijms.39542
work_keys_str_mv AT regulanaresh carbonfluxasameasureofprostatecanceraggressiveness11cacetatepetct
AT honarvarhadis carbonfluxasameasureofprostatecanceraggressiveness11cacetatepetct
AT lubberinkmark carbonfluxasameasureofprostatecanceraggressiveness11cacetatepetct
AT jorulfhakan carbonfluxasameasureofprostatecanceraggressiveness11cacetatepetct
AT ladjevardisam carbonfluxasameasureofprostatecanceraggressiveness11cacetatepetct
AT haggmanmichael carbonfluxasameasureofprostatecanceraggressiveness11cacetatepetct
AT antonigunnar carbonfluxasameasureofprostatecanceraggressiveness11cacetatepetct
AT buijsjos carbonfluxasameasureofprostatecanceraggressiveness11cacetatepetct
AT velikyanirina carbonfluxasameasureofprostatecanceraggressiveness11cacetatepetct
AT sorensenjens carbonfluxasameasureofprostatecanceraggressiveness11cacetatepetct